Why it went up you ask? - It's because of Chris Wardaugh4 May 2020 21:03
Not everyday do you see a Share rise like this, so it forced me to research a little.
The appointment of Chris Wardhaugh as stated in the RNS is critical for this to succeed. For those who do not know him, research his achievements. Some of them include:
Cheif Business Officer for MGB Biopharma - which is a biopharmaceutical company developing a novel class of anti-infectives to address the major global problem of antibiotic resistance.
Why is this important? - because Iclaprim which is in its phase III is an anti-biotic that treats skin diseases - it has reached 'Orphan status' in the U.S which is pretty big.
So why was he appointed by MGB Biopharma? - because they were in preparing to start PHASE II trial of MGB-BP-3 to assess the initial cure and sustained cure rates in the treatment of Clostridium difficile-associated diarrhoea (CDAD).
Why is this important - because Iclaprim is in the PHASE II/III stages and this guy has the experience and knowledge.
So what happened to that anti-infective medication - The company suddenly goes on to succeeding and getting it approved.
To cut the story short, and to save the best to last, the guy specialises in Company acquisitions and has bloody overseen the launch of 8 pharmaceutical products around the world. So everyone is in good hands. In fact, I might even join you guys in this.
Full info:
CHRIS WARDHAUGH has over 25 years of experience in the Life Science Sector including being Senior Director of Global Partnering of Quintiles and Head of Business Development and Operations Director of Prostrakan, among others. Most recently, Chris has been Senior Executive Advisor for Nanogenics, Senior Advisor for Clyde Biosciences and the Founder of Sercader Limited and previously he was Chief Operating Officer and President of Clyde Biosciences.
Mr Wardhaugh’s has significant transaction experience, including company acquisitions, funding rounds, market entries and IPOs. He has also overseen the launch of 8 pharmaceutical products (such as Tostran, Abstral, Rectogesic) in the USA, UK, Germany, France, Italy, Spain, The Netherlands, Belgium, and others.
https://www.mgb-biopharma.com/mgb-biopharma-expands-management-team-with-appointment-of-chris-wardhaugh-as-chief-business-officer/
Sign In
Follow the stocks
